Cargando…
COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study
Variation around the COL18A1 gene, which encodes the angiostatic peptide endostatin, may influence disease heterogeneity in pulmonary arterial hypertension https://bit.ly/3shXrNR
Autores principales: | Simpson, Catherine E., Griffiths, Megan, Yang, Jun, Nies, Melanie K., Vaidya, Dhananjay, Brandal, Stephanie, Martin, Lisa J., Pauciulo, Michael W., Lutz, Katie A., Coleman, Anna W., Austin, Eric D., Ivy, D. Dunbar, Nichols, William C., Everett, Allen D., Hassoun, Paul M., Damico, Rachel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234438/ https://www.ncbi.nlm.nih.gov/pubmed/35769420 http://dx.doi.org/10.1183/23120541.00725-2021 |
Ejemplares similares
-
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2021) -
Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
por: Daly, Caroline M., et al.
Publicado: (2021) -
Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
por: Yang, Jun, et al.
Publicado: (2022) -
Pediatric Pulmonary Hypertension: Insulin Like Growth Factor Binding Protein 2 is a novel marker associated with disease severity and survival
por: Griffiths, Megan, et al.
Publicado: (2020) -
Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival
por: Torres, Guillermo, et al.
Publicado: (2023)